IP Library Granted Patent US 6,900,204
Granted Patent B2
US 6,900,204 · App. 10/237,800 · Granted May 31, 2005

Antimicrobial agents and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,900,204
App. No.
10/237,800
Granted
May 31, 2005
Kind
B2
Abstract

The invention features compounds that act as antimicrobial agents and/or antimicrobial enhancer agents, compositions that include the antimicrobial enhancer agents of the invention, and methods for treating microbial infections using those compositions.

Claims (71)

1. A compound of formula I:

wherein A 1 and A 2 combine to form a fused ring described by formulas:

X 1 represents an oxygen atom.

R 1 represents H, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 -alkynyl, aryl, or heteroalkyl;

R 2 represents OR 3 , SR 3 , a hydrogen atom, or an alkyl group having 1 to 3 carbon atoms;

each R 3 , independently, represents H, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 -alkynyl, acyl, aryl, heteroalkyl, S(O) 1-2 —C 1-6 alkyl, S(O) 1-2 -aryl, S(O) 1-2 —C 2-6 alkenyl, or S(O) 1-2 —C 2-6 -alkynyl;

and R 4 represents a group expressed by the formula:

wherein each of R 5 and R 6 is, independently, an alkyl group having 1 to 7 carbon atoms,

or R 4 represents a group expressed by the formula:

in which g represents an integer between 1 and 3; or R 4 represents a group expressed by the formula:

wherein each of R 7 and R 8 is, independently, a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and X 2 represents an oxygen atom, a sulfur atom, a carbonyl group,

or X 2 represents a group expressed by the formula:

in which each of R 9 and R 10 is, independently, a hydrogen atom, or an alkyl group having 1 to 3 carbon atoms, or R 9 and R 10 , in combination with each other, represent —(CH 2 ) k — in which k represents an integer between 1 and 4;

or X 2 represents a group expressed by the formula:

in which m represents 0 or 1, R 11 represents a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or —(CH 2 ) n X 3 in which n represents an integer between 1 and 4, and X 3 represents a halogen atom, an alkoxy group having 1 to 3 carbon atoms, a vinyl group, or an ethynyl group,

or X 2 represents a group expressed by the formula:

2. The compound of claim 1 , wherein said compound is of formula II:

wherein

R 1 represents H, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 -alkynyl, aryl, or heteroalkyl;

R 2 represents OR 3 , SR 3 , a hydrogen atom, or an alkyl group having 1 to 3 carbon atoms;

Each R 3 , independently, represents C 1-6 alkyl, C 2-6 alkenyl, C 2-6 -alkynyl, acyl, aryl, heteroalkyl, S(O) 1-2 —C- 1-6 alkyl, S(O) 1-2 -aryl, S(O) 1-2 —C 2-6 alkenyl, or S(O) 1-2 —C 2-6 -alkynyl;

each of R 7 and R 8 is, independently, a hydrogen atom or an alkyl group having 1 to 3 carbon atoms;

X 1 represents an oxygen atom;

and X 2 represents a group expressed by the formula:

in which m represents 0 or 1, and R 11 represents a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or —(CH 2 ) n X 3 in which n represents an integer between 1 and 4, and X 3 represents a halogen atom, an alkoxy group having 1 to 3 carbon atoms, a vinyl group, or an ethynyl group.

3. The compound of claim 1 , wherein said compound is of formula III:

wherein

R 1 represents H, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 -alkynyl, aryl, or heteroalkyl;

R 2 represents OR 3 , SR 3 , a hydrogen atom, or an alkyl group having 1 to 3 carbon atoms;

each R 3 , independently, represents C 1-6 alkyl, C 2-6 alkenyl, C 2-6 -alkynyl, acyl, aryl, heteroalkyl, S(O) 1-2 —C 1-6 alkyl, S(O) 1-2 -aryl, S(O) 1-2 —C 2-6 alkenyl, or S(O) 1-2 —C 2-6 -alkynyl;

each of R 7 and R 8 is, independently, a hydrogen atom or an alkyl group having 1 to 3 carbon atoms;

X 1 represents an oxygen atom;

and X 2 represents a group expressed by the formula:

in which m represents 0 or 1, and R 11 represents a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or —(CH 2 ) n X 3 in which n represents an integer between 1 and 4, and X 3 represents a halogen atom, an alkoxy group having 1 to 3 carbon atoms, a vinyl group, or an ethynyl group.

4. A method of treating an infection of microbes selected from bacteria, fungi, and protozoans, or killing said microbes, said method comprising contacting said microbe or a site susceptible to microbial growth with a compound of claim 1 in an amount sufficient to treat said infection.

5. The method of claim 4 , wherein contacting said microbes comprises administering said compound to a mammal in an amount effective to treat a microbial infection.

6. The method of claim 5 , wherein said compound of claim 1 is administered in parallel with one or more antifungal agents, antibacterial agents, or antiprotozoan agents, or combinations thereof.

7. A method of enhancing the antimicrobial activity of an antimicrobial agent against a microbe, said method comprising:

a. contacting the microbe with the antimicrobial agent; and

b. contacting the microbe with a compound of claim 1 in an amount effective to increase the antimicrobial activity of the antimicrobial agent.

8. A method of treating disease associated with a bacterial infection in a patient, said method comprising administering to said patient a compound of claim 1 in amounts sufficient to treat said disease.

9. The method of claim 8 , wherein said disease in an inflammatory disease.

10. A pharmaceutical composition comprising an effective amount of a compound of claim 1 , or a suitable salt thereof, together with a pharmaceutically acceptable carrier or diluent.

11. The compound of claim 1 , wherein said compound has the structure:

12. The compound of claim 1 , wherein said compound has the structure:

13. The compound of claim 1 , wherein said compound has the structure:

14. The compound of claim 1 , wherein said compound has the structure:

15. The compound of claim 1 , wherein said compound has the structure:

16. The compound of claim 1 , wherein said compound has the structure:

17. The compound of claim 1 , wherein said compound has the structure:

18. The compound of claim 1 , wherein said compound has the structure:

19. The compound of claim 1 , wherein said compound has the structure:

20. The compound of claim 1 , wherein said compound has the structure:

21. The compound of claim 1 , wherein said compound has the structure:

22. The compound of claim 1 , wherein said compound has the structure:

23. The method of claim 4 , wherein said infection of microbes is an infection of bacteria.

24. The method of claim 23 , wherein said compound the structure:

25. The method of claim 23 , wherein said compound has the structure:

26. The method of claim 23 , wherein said compound has the structure:

27. The method of claim 23 , wherein said compound has the structure:

28. The method of claim 23 , wherein said compound has the structure:

29. The method of claim 23 , wherein said compound has the structure:

30. The method of claim 23 , wherein said compound has the structure:

31. The method of claim 23 , wherein said compound has the structure:

32. The method of claim 23 , wherein said compound has the structure:

33. The method of claim 23 , wherein said compound has the structure:

34. The method of claim 23 , wherein said compound has the structure:

35. The method of claim 23 , wherein said compound has the structure:

36. A method of enhancing the antibacterial activity of an antibacterial agent against bacteria, said method comprising:

a. contacting the bacteria with the antibacterial agent; and

b. contacting the bacteria with a compound of claim 1 in an amount effect to increase the antibacterial activity of the antibacterial agent.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2008
From: FINN JR.,JOSEPH F., AS ASSIGNEE FOR THE BENEFIT OF CREDITORS OF ACTIVBIOTICS, INC.
To: ACTIVBIOTICS PHARMA LLC
Reel/Frame 020866/0584 →
RELEASE OF SECURITY INTEREST Recorded Apr 18, 2008
From: HORIZON TECHNOLOGY FUNDING COMPANY LLC
To: ACTIVBIOTICS, INC.
Reel/Frame 020835/0427 →
SECURITY AGREEMENT Recorded Jan 7, 2008
From: ACTIVBIOTICS, INC.
To: HORIZON TECHNOLOGY FUNDING COMPANY, LLC
Reel/Frame 020325/0299 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2002
From: MICHAELIS, ARTHUR F.; MAULDING, HAWKINS V.
To: ACTIVBIOTICS, INC.
Reel/Frame 013592/0955 →